Overview OPS code search
OPS (operation and procedure) codes are used to classify various tests and treatments. They provide an important basis for the billing of medical services. The OPS codes are revised annually and are organized into the chapters mentioned below. Chapters 2, 4 and 7 were in an original version published by the World Health Organization (WHO) but are not used in the German healthcare system.
Please select the chapter for the OPS code you are looking for:
OPS code starting with “8”
- 8-01.- Administration of medication and nutrients
- 8-02.- Therapeutic injection
- 8-03.- Immunotherapy
- 8-10.- Foreign body removal
- 8-100.0.- Foreign body removal: Endoscopic foreign body removal: By otoscopy
- 8-100.1.- Foreign body removal: Endoscopic foreign body removal: By rhinoscopy
- 8-100.2.- Foreign body removal: Endoscopic foreign body removal: By laryngoscopy
- 8-100.30.- Foreign body removal: Endoscopic foreign body removal: By tracheoscopy: Using forceps
- 8-100.31.- Foreign body removal: Endoscopic foreign body removal: By tracheoscopy: Using cryoprobe
- 8-100.3x.- Foreign body removal: Endoscopic foreign body removal: By tracheoscopy: Other
- 8-100.40.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with flexible instrument: Using forceps
- 8-100.41.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with flexible instrument: Using cryoprobe
- 8-100.4x.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with flexible instrument: Other
- 8-100.50.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with rigid instrument: Using forceps
- 8-100.51.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with rigid instrument: Using cryoprobe
- 8-100.5x.- Foreign body removal: Endoscopic foreign body removal: By bronchoscopy, with rigid instrument: Other
- 8-100.7.- Foreign body removal: Endoscopic foreign body removal: By oesophagoscopy, with rigid instrument
- 8-100.8.- Foreign body removal: Endoscopic foreign body removal: By oesophago-gastroduodenoscopy
- 8-100.9.- Foreign body removal: Endoscopic foreign body removal: By colonoscopy/rectoscopy, with flexible instrument
- 8-100.a.- Foreign body removal: Endoscopic foreign body removal: By colonoscopy/rectoscopy, with rigid instrument
- 8-100.b.- Foreign body removal: Endoscopic foreign body removal: By urethrocystoscopy
- 8-100.c.- Foreign body removal: Endoscopic foreign body removal: By ureterorenoscopy
- 8-100.d.- Foreign body removal: Endoscopic foreign body removal: By hysteroscopy
- 8-100.x.- Foreign body removal: Endoscopic foreign body removal: Other
- 8-100.y.- Foreign body removal: Endoscopic foreign body removal: Unspecified
- 8-101.0.- Foreign body removal: Foreign body removal without incision: Superficial, from sclera
- 8-101.1.- Foreign body removal: Foreign body removal without incision: Superficial, from cornea
- 8-101.2.- Foreign body removal: Foreign body removal without incision: Superficial, from conjunctiva
- 8-101.3.- Foreign body removal: Foreign body removal without incision: From outer ear canal
- 8-101.4.- Foreign body removal: Foreign body removal without incision: From the nose
- 8-101.5.- Foreign body removal: Foreign body removal without incision: From the pharynx
- 8-101.6.- Foreign body removal: Foreign body removal without incision: From cervix uteri
- 8-101.7.- Foreign body removal: Foreign body removal without incision: From the vagina
- 8-101.8.- Foreign body removal: Foreign body removal without incision: From the vulva
- 8-101.9.- Foreign body removal: Foreign body removal without incision: From the urethra
- 8-101.a.- Foreign body removal: Foreign body removal without incision: Perianal
- 8-101.b.- Foreign body removal: Foreign body removal without incision: Anal
- 8-101.x.- Foreign body removal: Foreign body removal without incision: Other
- 8-101.y.- Foreign body removal: Foreign body removal without incision: Unspecified
- 8-102.0.- Foreign body removal: Foreign body removal from skin without incision: Lip
- 8-102.1.- Foreign body removal: Foreign body removal from skin without incision: Face
- 8-102.2.- Foreign body removal: Foreign body removal from skin without incision: Head and neck
- 8-102.3.- Foreign body removal: Foreign body removal from skin without incision: Shoulder, trunk and buttocks
- 8-102.4.- Foreign body removal: Foreign body removal from skin without incision: Groin and genital region
- 8-102.5.- Foreign body removal: Foreign body removal from skin without incision: Upper arm and elbow
- 8-102.6.- Foreign body removal: Foreign body removal from skin without incision: Forearm
- 8-102.7.- Foreign body removal: Foreign body removal from skin without incision: Hand
- 8-102.8.- Foreign body removal: Foreign body removal from skin without incision: Thigh and knee
- 8-102.9.- Foreign body removal: Foreign body removal from skin without incision: Lower leg
- 8-102.a.- Foreign body removal: Foreign body removal from skin without incision: Foot
- 8-102.x.- Foreign body removal: Foreign body removal from skin without incision: Other
- 8-102.y.- Foreign body removal: Foreign body removal from skin without incision: Unspecified
- 8-11.- Extracorporeal shockwave therapy
- 8-110.0.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in urinary organs: Bladder
- 8-110.1.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in urinary organs: Ureter
- 8-110.2.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in urinary organs: Kidney
- 8-110.x.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in urinary organs: Other
- 8-110.y.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in urinary organs: Unspecified
- 8-111.0.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in gall bladder and bile ducts: Gallbladder
- 8-111.1.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in gall bladder and bile ducts: Bile ducts
- 8-111.x.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in gall bladder and bile ducts: Other
- 8-111.y.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in gall bladder and bile ducts: Unspecified
- 8-112.0.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in other organs: Pancreas
- 8-112.1.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in other organs: Salivary glands
- 8-112.x.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in other organs: Other
- 8-112.y.- Extracorporeal shockwave therapy: Extracorporeal shockwave lithotripsy (EWSL) of stones in other organs: Unspecified
- 8-115.0.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Shoulder area
- 8-115.1.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Elbow
- 8-115.2.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Foot
- 8-115.3.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Long bone, upper limb
- 8-115.4.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Hand
- 8-115.5.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Long bone, lower limb
- 8-115.x.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Other
- 8-115.y.- Extracorporeal shockwave therapy: Extracorporeal shockwave therapy on musculoskeletal system: Unspecified
- 8-119.0.- Extracorporeal shockwave therapy: Other extracorporeal shockwave therapy: Penis
- 8-119.x.- Extracorporeal shockwave therapy: Other extracorporeal shockwave therapy: Other
- 8-119.y.- Extracorporeal shockwave therapy: Other extracorporeal shockwave therapy: Unspecified
- 8-12.- Manipulation of digestive tract
- 8-13.- Manipulation of urinary tract
- 8-14.- Other forms of therapeutic catheterization and cannulation
- 8-149.0.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Therapeutic probing of lacrimal passages
- 8-149.1.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Catheterization of accessory sinuses
- 8-149.2.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Catheterization of fallopian tube by hysteroscopy
- 8-149.3.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Therapeutic probing of lacrimal passages with intubation
- 8-149.x.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Other
- 8-149.y.- Other forms of therapeutic catheterization and cannulation: Other therapeutic catheterization and cannulation: Unspecified
- 8-15.- Therapeutic aspiration and evacuation by puncture
- 8-151.0.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Cistern
- 8-151.1.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Ventricle
- 8-151.2.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Ventriculoperitoneal shunt
- 8-151.3.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Spinal cyst
- 8-151.4.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Lumbar puncture
- 8-151.5.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Anterior chamber of eye
- 8-151.6.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Posterior chamber of eye
- 8-151.x.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Other
- 8-151.y.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of central nervous system and eye: Unspecified
- 8-156.0.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Hydrocele
- 8-156.1.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Spermatocele
- 8-156.2.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Prostate
- 8-156.3.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Seminal vesicle
- 8-156.x.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Other
- 8-156.y.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of male genital organs: Unspecified
- 8-157.0.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of female genital organs: Ovary
- 8-157.1.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of female genital organs: Uterus
- 8-157.x.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of female genital organs: Other
- 8-157.y.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of female genital organs: Unspecified
- 8-158.0.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Glenohumeral joint
- 8-158.1.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Acromioclavicular joint
- 8-158.2.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Scapulothoracic joint
- 8-158.3.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Sternoclavicular joint
- 8-158.4.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Humeroulnar joint
- 8-158.5.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Proximal radioulnar joint
- 8-158.6.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Distal radioulnar joint
- 8-158.7.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Wrist
- 8-158.8.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Radiocarpal joint
- 8-158.9.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Ulnocarpal joint
- 8-158.a.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Wrist
- 8-158.b.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Carpometacarpal joint
- 8-158.c.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Metacarpophalangeal joint
- 8-158.d.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Interphalangeal joint
- 8-158.e.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Sacroiliac joint
- 8-158.f.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Symphysis
- 8-158.g.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Hip joint
- 8-158.j.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Proximal tibiofibular joint
- 8-158.k.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Talocrural joint
- 8-158.m.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Subtalar joint
- 8-158.n.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Tarsal joint
- 8-158.p.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Tarsometatarsal joint
- 8-158.q.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Metatarsophalangeal joint
- 8-158.r.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Toe joint
- 8-158.s.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Mandibular joint
- 8-158.t.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Joints of the spine and ribs
- 8-158.x.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Other
- 8-158.y.- Therapeutic aspiration and evacuation by puncture: Therapeutic percutaneous puncture of joint: Unspecified
- 8-17.- Lavage
- 8-170.1.- Lavage: Therapeutic irrigation (lavage) of eye: Lacrimal ducts
- 8-170.x.- Lavage: Therapeutic irrigation (lavage) of eye: Other
- 8-170.y.- Lavage: Therapeutic irrigation (lavage) of eye: Unspecified
- 8-171.0.- Lavage: Therapeutic irrigation (lavage) of ear: Outer ear
- 8-171.1.- Lavage: Therapeutic irrigation (lavage) of ear: Middle ear
- 8-171.x.- Lavage: Therapeutic irrigation (lavage) of ear: Other
- 8-171.y.- Lavage: Therapeutic irrigation (lavage) of ear: Unspecified
- 8-172.- Lavage: Therapeutic irrigation (lavage) of sinuses
- 8-19.- Dressings and removal of diseased tissue on epidermis and hypodermis
- 8-20.- Closed reduction of fractured bone and dislocated joint without fixation
- 8-21.- Forcible correction of adhesions and deformities
- 8-22.- Manufacture and adjustment of facial epitheses
- 8-31.- Cast immobilization
- 8-39.- Positioning therapy
- 8-40.- Skeletal traction
- 8-41.- Spinal traction
- 8-50.- Tamponade for the control of bleeding
- 8-51.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period
- 8-510.0.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Manipulation of fetus prior to birth: External cephalic version (ECV)
- 8-510.1.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Manipulation of fetus prior to birth: Failed external cephalic version (ECV)
- 8-510.x.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Manipulation of fetus prior to birth: Other
- 8-510.y.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Manipulation of fetus prior to birth: Unspecified
- 8-515.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Assisted vaginal delivery
- 8-516.- Manipulation of fetus or uterus during pregnancy or in immediate postpartum period: Postpartum manual correction of uterine inversion
- 8-52.- Radiotherapy
- 8-53.- Nuclear medicine therapy
- 8-54.- Cytostatic chemotherapy, immunotherapy and antiretroviral therapy
- 8-55.- Complex treatment during early stage rehabilitation
- 8-56.- Individual physiotherapy measures
- 8-60.- Hyperthermia and hypothermia
- 8-63.- Electrical stimulation of nervous system
- 8-630.2.- Electrical stimulation of nervous system: Electroconvulsive therapy (ECT): Flat rate
- 8-630.3.- Electrical stimulation of nervous system: Electroconvulsive therapy (ECT): Treatment session
- 8-630.y.- Electrical stimulation of nervous system: Electroconvulsive therapy (ECT): Unspecified
- 8-631.0.- Electrical stimulation of nervous system: Neurostimulation: Reprogramming of implantable neurostimulator for brain stimulation
- 8-631.10.- Electrical stimulation of nervous system: Neurostimulation: Reprogramming of implantable neurostimulator for spine stimulation: Without pharmacological correction
- 8-631.11.- Electrical stimulation of nervous system: Neurostimulation: Reprogramming of implantable neurostimulator for spine stimulation: With pharmacological correction
- 8-631.20.- Electrical stimulation of nervous system: Neurostimulation: Reprogramming of implantable neurostimulator for peripheral nerve stimulation: Without pharmacological correction
- 8-631.21.- Electrical stimulation of nervous system: Neurostimulation: Reprogramming of implantable neurostimulator for peripheral nerve stimulation: With pharmacological correction
- 8-631.30.- Electrical stimulation of nervous system: Neurostimulation: Hypoglossal nerve stimulation system setup: Initial setup
- 8-631.31.- Electrical stimulation of nervous system: Neurostimulation: Hypoglossal nerve stimulation system setup: Reprogramming
- 8-631.4.- Electrical stimulation of nervous system: Neurostimulation: Phrenic nerve stimulation system setup
- 8-631.5.- Electrical stimulation of nervous system: Neurostimulation: Attachment or replacement of extracorporeal neurostimulator
- 8-631.x.- Electrical stimulation of nervous system: Neurostimulation: Other
- 8-631.y.- Electrical stimulation of nervous system: Neurostimulation: Unspecified
- 8-632.0.- Electrical stimulation of nervous system: Repetitive transcranial magnetic stimulation (rTMS): Flat rate
- 8-632.1.- Electrical stimulation of nervous system: Repetitive transcranial magnetic stimulation (rTMS): Treatment session
- 8-632.y.- Electrical stimulation of nervous system: Repetitive transcranial magnetic stimulation (rTMS): Unspecified
- 8-633.- Electrical stimulation of nervous system: Pharyngeal electrical stimulation (PES)
- 8-64.- Electrical reversion of cardiac arrhythmias
- 8-644.- Electrical reversion of cardiac arrhythmias: Testing or reprogramming of internal pacemakers, cardiac resynchronization therapy (CRT) systems or implantable defibrillators in children and adolescents under partial hospitalization
- 8-65.- Electrotherapy
- 8-650.- Electrotherapy: Electrotherapy
- 8-651.- Electrotherapy: Thermal therapy with magnetic nanoparticles
- 8-66.- Duration of focused ultrasound treatment
- 8-660.0.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): Up to 1 hour
- 8-660.1.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): 1 hours up to 2 hours
- 8-660.2.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): 2 hours up to 3 hours
- 8-660.3.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): 3 hours up to 4 hours
- 8-660.4.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): 4 hours up to 5 hours
- 8-660.5.- Duration of focused ultrasound treatment: Duration of magnetic resonance-guided focused ultrasound treatment (MRgFUS): 5 or more hours
- 8-70.- Access during mechanical ventilation and using airway clearance techniques
- 8-71.- Mechanical ventilation and respiratory assistance via face mask or tube and weaning from mechanical ventilation
- 8-72.- Administration of oxygen
- 8-77.- Resuscitation measures
- 8-80.- Blood cell transfusion
- 8-801.- Blood cell transfusion: Exchange transfusion
- 8-802.20.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: Without in vitro processing
- 8-802.21.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: With virus-specific in vitro processing
- 8-802.22.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: With fungus-specific in vitro processing
- 8-802.23.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: With tumor-specific in vitro processing, without in vitro genetic engineering
- 8-802.24.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: With tumor-specific in vitro processing, with in vitro genetic engineering
- 8-802.2x.- Blood cell transfusion: White cell transfusion: Lymphocytes, 1‑5 TU: With other in vitro processing
- 8-802.30.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: Without in vitro processing
- 8-802.31.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: With virus-specific in vitro processing
- 8-802.32.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: With fungus-specific in vitro processing
- 8-802.33.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: With tumor-specific in vitro processing, without in vitro genetic engineering
- 8-802.34.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: With tumor-specific in vitro processing, with in vitro genetic engineering
- 8-802.3x.- Blood cell transfusion: White cell transfusion: Lymphocytes, more than 5 TU: With other in vitro processing
- 8-802.40.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: Without in vitro processing
- 8-802.42.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With virus-specific in vitro processing
- 8-802.43.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With fungus-specific in vitro processing
- 8-802.44.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With tumor-specific in vitro processing
- 8-802.45.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With in vitro genetic engineering
- 8-802.46.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With in vitro depletion
- 8-802.4x.- Blood cell transfusion: White cell transfusion: Lymphocytes from the same donor with no further harvesting after hematopoietic stem cell transplantation: With other in vitro processing
- 8-802.50.- Blood cell transfusion: White cell transfusion: Leucocytes after ex vivo culture: T cells
- 8-802.51.- Blood cell transfusion: White cell transfusion: Leucocytes after ex vivo culture: Natural killer (NK) cells
- 8-802.52.- Blood cell transfusion: White cell transfusion: Leucocytes after ex vivo culture: Dendritic cells
- 8-802.5x.- Blood cell transfusion: White cell transfusion: Leucocytes after ex vivo culture: Other
- 8-802.60.- Blood cell transfusion: White cell transfusion: Granulocytes: 1 granulocyte concentrate
- 8-802.61.- Blood cell transfusion: White cell transfusion: Granulocytes: 2 granulocyte concentrates
- 8-802.62.- Blood cell transfusion: White cell transfusion: Granulocytes: 3 up to 5 granulocyte concentrates
- 8-802.63.- Blood cell transfusion: White cell transfusion: Granulocytes: 5 up to 7 granulocyte concentrates
- 8-802.64.- Blood cell transfusion: White cell transfusion: Granulocytes: 7 up to 9 granulocyte concentrates
- 8-802.65.- Blood cell transfusion: White cell transfusion: Granulocytes: 9 up to 11 granulocyte concentrates
- 8-802.66.- Blood cell transfusion: White cell transfusion: Granulocytes: 11 up to 13 granulocyte concentrates
- 8-802.67.- Blood cell transfusion: White cell transfusion: Granulocytes: 13 up to 15 granulocyte concentrates
- 8-802.68.- Blood cell transfusion: White cell transfusion: Granulocytes: 15 up to 17 granulocyte concentrates
- 8-802.69.- Blood cell transfusion: White cell transfusion: Granulocytes: 17 up to 19 granulocyte concentrates
- 8-802.6a.- Blood cell transfusion: White cell transfusion: Granulocytes: 19 up to 21 granulocyte concentrates
- 8-802.6b.- Blood cell transfusion: White cell transfusion: Granulocytes: 21 or more granulocyte concentrates
- 8-802.70.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: Without in vitro processing
- 8-802.71.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With virus-specific in vitro processing
- 8-802.72.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With fungus-specific in vitro processing
- 8-802.73.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With tumor-specific in vitro processing
- 8-802.74.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With in vitro genetic engineering
- 8-802.75.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With in vitro depletion
- 8-802.7x.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from the same donor after hematopoietic stem cell transplantation: With other in vitro processing
- 8-802.80.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: Without in vitro processing
- 8-802.81.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: With virus-specific in vitro processing
- 8-802.82.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: With fungus-specific in vitro processing
- 8-802.83.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: With tumor-specific in vitro processing
- 8-802.84.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: With in vitro depletion
- 8-802.8x.- Blood cell transfusion: White cell transfusion: Lymphocytes after further harvesting from a different donor after hematopoietic stem cell transplantation: With other in vitro processing
- 8-802.x.- Blood cell transfusion: White cell transfusion: Other
- 8-802.y.- Blood cell transfusion: White cell transfusion: Unspecified
- 8-81.- Transfusion of plasma, plasma components and infusion of volume replacement fluids
- 8-811.0.- Transfusion of plasma, plasma components and infusion of volume replacement fluids: Infusion of volume replacement fluids in newborns: Single infusion (1-5 units)
- 8-811.1.- Transfusion of plasma, plasma components and infusion of volume replacement fluids: Infusion of volume replacement fluids in newborns: Mass infusion (> 5 units)
- 8-811.x.- Transfusion of plasma, plasma components and infusion of volume replacement fluids: Infusion of volume replacement fluids in newborns: Other
- 8-811.y.- Transfusion of plasma, plasma components and infusion of volume replacement fluids: Infusion of volume replacement fluids in newborns: Unspecified
- 8-82.- Plasmapheresis, immunoadsorption and related procedures
- 8-822.- Plasmapheresis, immunoadsorption and related procedures: LDL apheresis
- 8-823.- Plasmapheresis, immunoadsorption and related procedures: Cytoapheresis
- 8-824.- Plasmapheresis, immunoadsorption and related procedures: Photopheresis
- 8-825.0.- Plasmapheresis, immunoadsorption and related procedures: Specialized cytoapheresis methods: Cytoapheresis with granulocyte and monocyte adsorption on cellulose acetate beads
- 8-825.1.- Plasmapheresis, immunoadsorption and related procedures: Specialized cytoapheresis methods: Cytoapheresis with granulocyte, monocyte and lymphocyte adsorption in polypropylene adsorption filter
- 8-825.x.- Plasmapheresis, immunoadsorption and related procedures: Specialized cytoapheresis methods: Other
- 8-83.- Therapeutic intravascular catheterization and cannulation
- 8-83c.gb.- Therapeutic intravascular catheterization and cannulation: Other (percutaneous) transluminal angioplasty: Endovascular creation of arteriovenous fistula by inserting stent grafts for deep vein arterialization: Vessels of the thigh
- 8-83c.gc.- Therapeutic intravascular catheterization and cannulation: Other (percutaneous) transluminal angioplasty: Endovascular creation of arteriovenous fistula by inserting stent grafts for deep vein arterialization: Vessels of the lower leg
- 8-83c.gx.- Therapeutic intravascular catheterization and cannulation: Other (percutaneous) transluminal angioplasty: Endovascular creation of arteriovenous fistula by inserting stent grafts for deep vein arterialization: Other
- 8-83c.h0.- Therapeutic intravascular catheterization and cannulation: Other (percutaneous) transluminal angioplasty: Temporary stent angioplasty for cerebrovascular vasospasm: Intracranial vessels
- 8-83c.hx.- Therapeutic intravascular catheterization and cannulation: Other (percutaneous) transluminal angioplasty: Temporary stent angioplasty for cerebrovascular vasospasm: Other
- 8-84.- (Percutaneous) transluminal stent implantation
- 8-85.- Extracorporeal circulation and treatment of blood
- 8-86.- Autologous and allogeneic stem cell therapy and local treatment with blood components and hepatocytes
- 8-90.- Anesthesia
- 8-91.- Pain therapy
- 8-92.- Neurological monitoring
- 8-93.- Monitoring of cardiovascular and respiratory systems
- 8-97.- Complex multimodal treatment
- 8-971.0.- Complex multimodal treatment: Complex multimodal dermatological treatment: Whole body dermatotherapy (minimum 2 × daily)
- 8-971.1.- Complex multimodal treatment: Complex multimodal dermatological treatment: Whole body dermatotherapy (minimum 2 × daily), balneotherapy and/or light therapy
- 8-971.2.- Complex multimodal treatment: Complex multimodal dermatological treatment: Whole body dermatotherapy (minimum 2 × daily), balneotherapy and/or light therapy, allergen, dietary (elimination diets) and/or psychosomatic measures
- 8-971.3.- Complex multimodal treatment: Complex multimodal dermatological treatment: Whole body dermatotherapy (minimum 2 × daily), balneotherapy and/or light therapy, allergen, dietary (elimination diets) and/or psychosomatic measures, patient-specific parenteral infusion therapy
- 8-971.4.- Complex multimodal treatment: Complex multimodal dermatological treatment: Whole body dermatotherapy (minimum 2 × daily), balneotherapy and/or light therapy, allergen, dietary (elimination diets) and/or psychosomatic measures, patient-specific parenteral infusion therapy, patient training (parent/child where appropriate)
- 8-971.x.- Complex multimodal treatment: Complex multimodal dermatological treatment: Other
- 8-971.y.- Complex multimodal treatment: Complex multimodal dermatological treatment: Unspecified
- 8-972.0.- Complex multimodal treatment: Complex treatment for treatment refractory epilepsy: Minimum 7 to maximum 13 days of treatment
- 8-972.1.- Complex multimodal treatment: Complex treatment for treatment refractory epilepsy: Minimum 14 to maximum 20 days of treatment
- 8-972.2.- Complex multimodal treatment: Complex treatment for treatment refractory epilepsy: Minimum 21 days of treatment
- 8-973.- Complex multimodal treatment: Complex treatment for spina bifida
- 8-975.22.- Complex multimodal treatment: Complex naturopathy and anthroposophical medicine treatment: Complex naturopathy treatment: Minimum of 7 to maximum of 13 days of treatment and less than 1,680 minutes of treatment
- 8-975.23.- Complex multimodal treatment: Complex naturopathy and anthroposophical medicine treatment: Complex naturopathy treatment: Minimum of 14 to maximum of 20 days of treatment and less than 2,520 minutes of treatment or minimum of 10 to maximum of 13 days of treatment and minimum of 1,680 minutes of treatment
- 8-975.24.- Complex multimodal treatment: Complex naturopathy and anthroposophical medicine treatment: Complex naturopathy treatment: Minimum of 21 days of treatment or minimum of 14 days of treatment and minimum of 2,520 minutes of treatment
- 8-975.3.- Complex multimodal treatment: Complex naturopathy and anthroposophical medicine treatment: Complex anthroposophical medicine treatment
- 8-976.00.- Complex multimodal treatment: Complex treatment for paraplegia: Comprehensive initial treatment: Up to 99 days of treatment
- 8-976.01.- Complex multimodal treatment: Complex treatment for paraplegia: Comprehensive initial treatment: Minimum 100 to maximum 199 days of treatment
- 8-976.02.- Complex multimodal treatment: Complex treatment for paraplegia: Comprehensive initial treatment: Minimum 200 to maximum 299 days of treatment
- 8-976.03.- Complex multimodal treatment: Complex treatment for paraplegia: Comprehensive initial treatment: Minimum 300 days of treatment
- 8-976.10.- Complex multimodal treatment: Complex treatment for paraplegia: Treatment on the basis of direct or associated consequences: Up to 17 days of treatment
- 8-976.11.- Complex multimodal treatment: Complex treatment for paraplegia: Treatment on the basis of direct or associated consequences: Minimum 18 to maximum 49 days of treatment
- 8-976.12.- Complex multimodal treatment: Complex treatment for paraplegia: Treatment on the basis of direct or associated consequences: Minimum 50 to maximum 99 days of treatment
- 8-976.13.- Complex multimodal treatment: Complex treatment for paraplegia: Treatment on the basis of direct or associated consequences: Minimum 100 days of treatment
- 8-976.2.- Complex multimodal treatment: Complex treatment for paraplegia: Treatment based on lifelong aftercare (check)
- 8-977.- Complex multimodal treatment: Complex, multimodal non-surgical treatment of motor system
- 8-978.- Complex multimodal treatment: Maintenance of homeostasis for post-mortem organ donation
- 8-97a.0.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for cerebrovascular vasospasm: Up to 6 days of treatment
- 8-97a.1.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for cerebrovascular vasospasm: Minimum 7 to maximum 13 days of treatment
- 8-97a.2.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for cerebrovascular vasospasm: Minimum 14 days of treatment
- 8-97b.0.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for neuromuscular disease: Up to 6 days of treatment
- 8-97b.1.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for neuromuscular disease: Minimum 7 to maximum 13 days of treatment
- 8-97b.2.- Complex multimodal treatment: Multimodal intensive care monitoring and treatment for neuromuscular disease: Minimum 14 days of treatment
- 8-97d.0.- Complex multimodal treatment: Complex multimodal treatment for Parkinson’s and atypical parkinsonian syndrome: Minimum 7 to maximum 13 days of treatment
- 8-97d.1.- Complex multimodal treatment: Complex multimodal treatment for Parkinson’s and atypical parkinsonian syndrome: Minimum 14 to maximum 20 days of treatment
- 8-97d.2.- Complex multimodal treatment: Complex multimodal treatment for Parkinson’s and atypical parkinsonian syndrome: Minimum 21 days of treatment
- 8-97e.0.- Complex multimodal treatment: Late-stage treatment of Parkinson’s with infusion pumps: Initial medication with apomorphine
- 8-97e.1.- Complex multimodal treatment: Late-stage treatment of Parkinson’s with infusion pumps: Therapeutic drug monitoring and optimization of treatment with apomorphine
- 8-97e.2.- Complex multimodal treatment: Late-stage treatment of Parkinson’s with infusion pumps: Initial medication with L-dopa gel
- 8-97e.3.- Complex multimodal treatment: Late-stage treatment of Parkinson’s with infusion pumps: Therapeutic drug monitoring and optimization of treatment with L-dopa gel
- 8-98.- Other complex multimodal treatment
- 8-983.0.- Other complex multimodal treatment: Complex multimodal rheumatological treatment: Minimum 7 to maximum 13 days of treatment
- 8-983.1.- Other complex multimodal treatment: Complex multimodal rheumatological treatment: Minimum 14 to maximum 20 days of treatment
- 8-983.2.- Other complex multimodal treatment: Complex multimodal rheumatological treatment: Minimum 21 days of treatment
- 8-985.0.- Other complex multimodal treatment: Motivational treatment for substance dependency (comprehensive detoxification): Up to 6 days of treatment
- 8-985.1.- Other complex multimodal treatment: Motivational treatment for substance dependency (comprehensive detoxification): Minimum 7 to maximum 13 days of treatment
- 8-985.2.- Other complex multimodal treatment: Motivational treatment for substance dependency (comprehensive detoxification): Minimum 14 to maximum 20 days of treatment
- 8-985.3.- Other complex multimodal treatment: Motivational treatment for substance dependency (comprehensive detoxification): Minimum 21 days of treatment
- 8-986.0.- Other complex multimodal treatment: Complex multimodal rheumatological treatment in children and adolescents: Minimum 7 to maximum 13 days of treatment
- 8-986.1.- Other complex multimodal treatment: Complex multimodal rheumatological treatment in children and adolescents: Minimum 14 to maximum 20 days of treatment
- 8-986.2.- Other complex multimodal treatment: Complex multimodal rheumatological treatment in children and adolescents: Minimum 21 days of treatment
- 8-988.0.- Other complex multimodal treatment: Specialized complex treatment of hand: Up to 6 days of treatment
- 8-988.1.- Other complex multimodal treatment: Specialized complex treatment of hand: Minimum 7 to maximum 13 days of treatment
- 8-988.2.- Other complex multimodal treatment: Specialized complex treatment of hand: Minimum 14 to maximum 20 days of treatment
- 8-988.3.- Other complex multimodal treatment: Specialized complex treatment of hand: Minimum 21 days of treatment
- 8-98a.0.- Other complex multimodal treatment: Complex geriatric treatment under partial hospitalization: Basic treatment
- 8-98a.10.- Other complex multimodal treatment: Complex geriatric treatment under partial hospitalization: Comprehensive treatment: 60 to 90 minutes of therapy time per day in individual and/or group therapy
- 8-98a.11.- Other complex multimodal treatment: Complex geriatric treatment under partial hospitalization: Comprehensive treatment: More than 90 minutes of therapy time per day in individual and/or group therapy
- 8-99.- Additional information on non-surgical therapeutic measures
